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Abstract
Proteomics experiments typically involve protein or peptide separation steps coupled to the
identification of many hundreds to thousands of peptides by mass spectrometry. Development of
methodology and instrumentation in this field is proceeding rapidly, and effective software is
needed to link the different stages of proteomic analysis. We have developed an application,
proteogest, written in Perl that generates descriptive and statistical analyses of the biophysical
properties of multiple (e.g. thousands) protein sequences submitted by the user, for instance
protein sequences inferred from the complete genome sequence of a model organism. The
application also carries out in silico proteolytic digestion of the submitted proteomes, or subsets
thereof, and the distribution of biophysical properties of the resulting peptides is presented.
proteogest is customizable, the user being able to select many options, for instance the cleavage
pattern of the digestion treatment or the presence of modifications to specific amino acid residues.
We show how proteogest can be used to compare the proteomes and digested proteome products
of model organisms, to examine the added complexity generated by modification of residues, and
to facilitate the design of proteomics experiments for optimal representation of component
proteins.
Introduction
Proteomics involves the large-scale or global analysis of
the protein complement of an organism [1–3]. The con-
vergence of several factors has led to the rapid emergence
of proteomics as a distinct and promising scientific field,
notably the completion of genome sequencing projects
and advances in sensitive high-throughput protein analy-
sis methods such as mass spectrometry (MS). Proteomics
studies can generate massive amounts of experimental
data. A single bacterial cell may produce 4000 proteins
whose abundances and activities may vary throughout an
experiment, while the number of proteins expressed in
higher eukaryotes is likely to be at least 10-fold greater.
Attempts to catalogue, visualize, and analyze proteomics
experiments have therefore become a major challenge. In
fact, the development of practical software applications
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suitable for theoretical and experimental analysis of the
proteome lags far behind that for the analysis of genomes
and DNA.
A fundamental operation of proteomics is to identify pro-
teins. For most high-throughput applications, proteins are
cleaved with site-specific reagents, for example cyanogen
bromide (CNBr) or proteases (usually trypsin), to gener-
ate smaller peptides better suited to analysis by MS. In
shotgun proteomics studies, entire mixtures of proteins
are digested. Most proteomics experiments involve four
steps: a) protein isolation from a biological sample (e.g. a
cell extract) following some experimental treatment; b)
fractionation of the resulting proteins (or peptides, the
products of proteome digestion) by methods such as two-
dimensional polyacrylamide gel electrophoresis (2D-
PAGE) or liquid chromatography (LC); c) protein or pep-
tide detection by MS; d) protein identification through
manual interpretation or database correlation of mass
spectra. Integration of these steps is essential for a success-
ful proteome experiment yet relies on accurate knowledge
of the parameters influencing each step. Tools that effec-
tively link the predicted proteome or digested proteome
to the data obtained in proteomics experiments are there-
fore necessary for several reasons. First, they provide a sta-
tistical framework that can facilitate interpretation of the
output of protein identification algorithms such as MS-Fit
and MS-Tag [4] or SEQUEST [5]. Second, failure to
observe an expected protein in a proteomics experiment
may be for several reasons, including limits to MS detec-
tion technology, poor expression or recovery of the pro-
tein, or because the protein identification algorithm is
inefficient. While recent studies have confirmed the pres-
ence of many proteins previously only predicted by their
cognate DNA sequences [6], likewise a large number of
predicted protein species have never been observed, and
software tools can highlight experimental factors that
might contribute to these discrepancies. Third, while the
genomic DNA sequence is believed to contain all the
information needed to describe the protein products of
the cell, our knowledge of non-canonical proteins (i.e.
proteins other than those that are defined by uninter-
rupted start and stop codons and whose component resi-
dues are unmodified) is very incomplete. The set of
canonical proteins for a given organism will probably be
expanded several-fold by the phenomena of post-tran-
scriptional splicing and post-translational modification.
Software that can analyze data on a whole proteome scale
is required for examining such expanded proteomes.
Programs that can analyze several aspects of protein bio-
chemistry and structure are available at websites such as
the Swiss Institute of Bioinformatics http://www.isb-
sib.ch and the European Bioinformatics Institute http://
www.ebi.ac.uk/proteome/. These programs are generally
not suited to processing of whole proteomes, nor are they
designed to analyze the peptide digestion products of
entire proteomes. A software application that can mimic
proteome digestion and analyze the resulting peptides on
a whole proteome scale would be of great value to the
mass spectrometry researcher. We therefore developed
proteogest, a program that generates basic descriptive statis-
tics for both the intact and proteolytically processed
proteome.
Results
An analytical tool for proteomics
proteogest is written in Perl and runs in command line
mode with several options. A detailed description of how
to install and run proteogest is available for download at
http://www.utoronto.ca/emililab/program/proteo
gest.htm
Protein sequences to be analyzed are saved as a text file in
FASTA format in the same directory as the proteogest pro-
gram. Text files can be edited to suit the user, for instance
to contain all the proteins predicted for a particular organ-
ism, or a similar list with predicted transmembrane pro-
teins removed. The user specifies the cleavage criteria by
inserting an 'X' character into the cleavage sequence e.g.
"SXS" would cleave in the middle of two successive S res-
idues. Where alternative residues may be cleaved, the
alternatives are separated by a comma, "PX,QX,RX". The
'Z' character can be used as a wild card, for instance
"QZZYZQXS" would mimic the tobacco etch virus pro-
tease recognition site where cleavage occurs after the sec-
ond glutamine (Q) and tolerates several different residues
at positions 2, 3, and 5. In the laboratory, the activity of
proteolytic enzymes and chemical reagents may be
incomplete, resulting in a subset of digestion products
that contain cleavage sites that remain unprocessed. In
order to simulate this, an option to specify the maximum
number of missed cleavages per digestion product is
included. When this option is chosen, the output
describes all possible complete and incomplete cleavages.
For instance, by choosing "2", all peptides containing 0, 1
or 2 missed cleavages are described (not just those where
2 cleavage sites are present).
Several post-translational modification options may be
used. A peptide can be modified by phosphorylation (in
this case, +80.0 amu can be added to every occurrence of
serine, threonine or tyrosine, or iteratively to only one of
each separate STY residues) or the user can specify any
combination of custom modifications. A number of
groups have described promising methods for phospho-
proteome analysis recently [7–9] (reviewed in reference
10).
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Modifications using quantitative chemical adducting rea-
gents such as the ICAT (Isotope-Coded Affinity Tag;
[11,12]) or MCAT (Mass-Coded Abundance Tag; [13]) are
also available and the program can be run in modes that
assume all (considers all specified residues as modified)
or some (considers specified residues occurring in both
modified and unmodified form) proteins or proteins
digestion products as modified. This mimics the natural
proteome environment where proteins may exist in differ-
entially modified states. The user may vary the output file
format. 'Simple' reports (Fig. 1A) and 'Annotated' reports
(Fig. 1B) are text files that contain descriptive lists of the
proteome digestion products, and can serve as the input
for other programs, for a database, or for computational
or visualization applications. These reports can be very
large (for instance, the set of 25,931 known or predicted
human proteins produces 1,175,015 peptides when
digested with trypsin) so they are not produced by default.
The 'Summary' report is an html document that provides
an overview of the processed proteome using descriptive
statistics of the parent proteins and the digested daughter
peptides. The mean, standard deviation, and range of
properties such as protein length, molecular mass are
noted and the distribution of these physical properties
and properties such as amino acid occurrence are
described in a series of tables (Fig. 1C). In another section,
similar properties are described for the proteome diges-
tion products (Fig. 1D). These data are useful for research-
ers planning proteomics experiments using many
different fractionation and detection approaches. For
example, an investigator planning a HPLC-MS experiment
following peptide capture with a tryptophan-binding rea-
gent needs to know both the frequency of tryptophan-
containing peptides among parent proteins and the size
distribution of those peptides, the former to estimate the
representation of the captured peptides and the latter to
focus the efforts of the mass spectrometer to the correct
mass-to-charge (m/z) range. As well as length, mass, and
amino acid representation, charge is predicted for each
peptide. The report ends with descriptions of potential
phosphorylation and user-defined modifications, as well
as statistics describing the extent of redundancy (the
occurrence of the same peptide sequence two or more
times) among the products.
Computational proteome analysis of model organisms
proteogest was written to analyze large proteome amino
acid sequence datasets and to simulate digestion of the
proteome with enzymes or chemical reagents. Here we
refer to the theoretical proteome as the entire potential
protein complement encoded by the genetic component
of a cell or organism, and distinguish it from the observed
or experimental proteome, or the complement of proteins
that are actually expressed under physiological or experi-
mental conditions. This definition of the proteome
includes the primary gene products defined by start and
stop codons but does not exclude variants of those gene
products arising from mRNA splicing or post-transla-
tional proteolysis or modification.
We used proteogest to compare the distribution of protein
characteristics for the proteomes of a number of model
organisms, including both eukaryotes and prokaryotes.
Although the distribution of protein size (Mr) is roughly
similar for all seven organisms examined, eukaryotic
organisms tend to express larger proteins than prokaryo-
tes, with for example the average human protein having
mass 51,801 Da while a typical E. coli protein is 35,005 Da
(Fig. 2A). Next, we compared the occurrence of the 20
amino acids for each protein in the complete predicted
proteome sets. For clarity, analyses of only three pro-
teomes, E. coli, S. cerevisiae and H. sapiens, are shown (Fig.
2B). The columns for each amino acid residue are
arranged in the figure from left to right according to their
frequency in yeast, and it is observed that while some
amino acids are favoured (e.g. leucine) or disfavoured
(e.g. tryptophan) in all three organisms, there is consider-
able variation in occurrence. Because the most common
method of digesting proteins into peptides in proteomics
experiments is the use of trypsin, it is interesting to note
that the combined frequency of the amino acids lysine
and arginine (trypsin generally cleaves carboxy-terminal
to lysine and arginine) varies from a low of 8.8% of all
amino acids in E. coli up to 12.1% in M. jannaschii (data
not shown).
For many laboratory proteomics procedures, it is useful to
know exactly how specific residues are distributed. Figure
3 shows that the distribution of different amino acids
among proteins varies significantly in the model organ-
isms. The distribution of a common residue like alanine is
clearly different from that of a relatively rare residue like
tryptophan in the proteomes of the organisms examined.
Where the distribution appears to differ between organ-
isms, for instance the distribution of serine, they can gen-
erally be accounted for by differences in average protein
size. For instance, the fraction of proteins having less than
20 serine residues per protein is almost double for E. coli
than for S. cerevisiae or H. sapiens (the average number of
serines per protein in these organisms is 18.25, 42.22 and
38.81 respectively), but the corresponding protein lengths
are 305.58, 458.27 and 460.41.
Another use of proteogest is for searching proteome data-
sets for potential binding sites and consensus sequences.
For instance, metal affinity capture using Nickel conju-
gated resins is often used to recover recombinant proteins
from E. coli and S. cerevisiae. Interestingly, the sequence
HHHHHH (His6) occurs only once in the predicted E. coli
proteome (the His operon attenuator leader peptide)
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Screen captures of the proteogest output filesFigure 1
Screen captures of the proteogest output files. The Methanococcus jannaschii proteome was digested C-terminal to lysine and 
arginine residues (cleavage criteria "KX,RX"). A) The 'Simple' file lists the peptide products of each protein, their isotopic and 
average molecular masses, and their sequence; B) The 'Annotated' file also lists the peptide products of each protein, along 
with the counts of each amino acid residue for each peptide; C) A screen capture from the Protein Analysis section of the 
'Summary' file; D) A screen capture from the Peptide Analysis section of the 'Summary' file.
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Characteristics of proteins in the predicted proteomes of model organismsFigure 2
Characteristics of proteins in the predicted proteomes of model organisms. A) Distribution of protein length; B) Mean amino 
acid residue frequency per protein.
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while it is present in 17 predicted S. cerevisiae proteins. In
contrast, only two E. coli proteins (multidrug resistance
protein B and hypothetical protein yciQ) and four S. cere-
visiae proteins (AFG3, SCJ1, YLR338W and hypothetical
protein YJE8) contain polyglutamine tracts longer than
five residues.
The experimentally determined proteome is likely to
reflect biases introduced by the methodology used to
characterize it. To assess this, we used proteogest to com-
pare the predicted S. cerevisiae proteome to FASTA files
representing three sets of proteomic data obtained using
the approaches most commonly used in published pro-
teomics studies. One set contains 157 proteins identified
following separation on 2D gels [14,15] and another con-
tains 164 proteins identified in our laboratory using
microflow liquid chromatography coupled online to tan-
dem mass spectrometry. A third set contains 1436 pro-
teins that were identified in multi-dimensional protein
identification technology (MudPIT) experiments ([6], G.
Cagney & A. Emili; unpublished). In MudPIT, successive
LC online fractionation steps are carried out on fractions
eluted from strong cation exchange media packed in the
same chromatography column that houses reverse phase
media [16]. MudPIT therefore represents an orthogonal
2D separation technology and is capable of separating
many hundreds to thousands of peptides in a single exper-
iment. Comparison of the sets shows clear biases in the
Distribution of alanine-, tryptophan-, serine-, and cysteine-containing proteins in predicted proteomes of model organismsFigure 3
Distribution of alanine-, tryptophan-, serine-, and cysteine-containing proteins in predicted proteomes of model organisms.
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Comparison of methods for identifying experimental proteomesFigure 4
Comparison of methods for identifying experimental proteomes. Experimental proteomes were determined using MALDI MS 
or nano-electrospray MS following 2D gel protein separation (2D gel), 1D liquid chromatography peptide separation with 
nano-electrospray MS (1D LC), or 2D peptide separation by 2D chromatography (strong cation exchange and reverse phase 
chromatography) with nano-electrospray MS (MUDPIT). 'Proteome' represents all predicted yeast proteins. Protein length in 
residues (A), isoelectric point (B), and codon adaption index, CAI (C), are shown. MUDPIT data were obtained from reference 
6 and our laboratory; 1D LC data are from our laboratory; 2D gel data are from references 14 and 15.
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methodologies (Fig. 4). Small proteins (<200 amino
acids) were poorly recovered from 2D gels, whereas the
size profile of proteins identified following 1D reverse
phase chromatography more closely resembled that of the
proteome (all predicted yeast proteins). Proteins with
high isoelectric point were also poorly represented in pro-
teome samples fractionated using 2D gels. The MudPIT
approach was perhaps most representative of the pro-
teome, with a similar profile for proteins above 300 resi-
dues in length, although significantly fewer proteins in
the 100–200 amino acid range are seen using MudPIT
than are expected from the predicted proteome. This may
result from larger proteins giving proportionally more
positive identifications because there are more peptides
per protein for the mass spectrometer to detect. This effect
is not as noticeable for 2D gel or 1D chromatography
because the numbers of proteins normally detected per
experiment (~150) is significantly lower than for MudPIT
experiments (~1500). These conclusions are supported by
protein abundance estimates (Fig. 4C). Of the proteome
analysis methods examined, the distribution of codon
adaptation indices (CAI) for proteins detected by MudPIT
most closely resembled the distribution predicted from
the theoretical proteome, although only about half the
proportion of very poorly expressed proteins (CAI < 0.15)
are observed in MudPIT samples compared to the theoret-
ical proteome. Separation of proteome components using
2D gels also appears capable of identifying moderately
abundant proteins, while 1D LC appears to be mostly lim-
ited to abundant proteins. The absence of a second frac-
tionation dimension and the relatively short analysis time
explain the underperformance of 1D LC when analyzing
highly complex proteomic mixtures; these levels of sensi-
tivity and ease of use may be perfectly adequate when ana-
lyzing less complex mixtures however. This type of
analysis is possible using proteogest, where sets of pro-
teins from any source can be analyzed for simple biophys-
ical properties like digestion product size distribution.
Analysis of the digested and modified proteome
We next used proteogest to compare the digestion products
of the proteome of S. cerevisiae using reagents commonly
used to generate peptides. Treatment of the proteome
with trypsin (cleaves C-terminal to lysine or arginine,
except before proline), chymotrypsin (cleaves C-terminal
to hydrophobic residues), Endo Asp N (cleaves N-termi-
nal to aspartic acid), or cyanogen bromide (cleaves C-ter-
minal to methionine when the reaction is carried out in
formic acid) result in different product properties (Table
1). On average, treatment of with chymotrypsin yields an
average of 35.0 peptides per protein compared with 9.6
peptides per protein following treatment with cyanogen
bromide, reflecting the frequency of the corresponding
cleavage sites in the yeast proteome. The mean product
mass following digestion with trypsin (41.9 peptides per
protein for S. cerevisiae) is just over 1000 Da for all organ-
isms tested (data not shown), a convenient size for analy-
sis by commercial time-of-flight and ion trap mass
spectrometers. Combination digestions are sometimes
used in the lab, for instance cleavage by cyanogen bro-
mide followed by trypsin – these combinations can also
be modelled by proteogest. Note however, that when one
missed trypsin cleavage per product was permitted in a
simulated digestion of the yeast proteome using proteogest,
the mean peptide size increased to 1637.4 Da while the
complexity of the mixture (total number of distinct pep-
tides) doubled. Permitting two missed trypsin cleavages
continues this trend, yielding mean peptide size of 2078.5
and tripling the total number of peptides compared to the
completely digested proteome. Missed cleavages more
closely resemble the situation in the laboratory, where it
is difficult to ensure complete trypsin digestion of com-
plex mixtures.
The distribution of proteome digestion product masses is
of interest to the proteomics investigator because either
the ability of the mass analyzer to resolve peptides with
similar mass-to-charge (m/z) ratio, or the instrument time
needed to sample all the peptides, or both, are often satu-
rated. The experimenter must therefore focus instrument
resources on the regions yielding most information.
Trypsin is the enzyme of choice for generating peptides for
mass spectrometry because it produces peptides with
masses compatible with the detection abilities of com-
monly used mass spectrometers (up to approximately
2000 m/z), while many peptides are long enough to gen-
erate useful sequence data by collision induced dissocia-
tion. Peptides larger than 2000 Da can be analyzed using
ion trap and quadrupole mass analyzers if the peptides
have charge greater than one, resulting in m/z ratios
within the effective detection range of the instruments. A
large number of information poor peptides of less than
700 Da are typically formed by trypsin digestion. When
proteogest was used to catalogue the set of predicted tryptic
peptides from S. cerevisiae (omitting peptides with six or
fewer residues), it was observed that the majority of pep-
tides have mass between 800 and 1200 Daltons (Fig. 5A).
In direct contrast, peptides identified in our lab (from sev-
eral MUDPIT analyses of yeast whole cell protein) are
evenly distributed across the range 700–1600 Da (Fig.
5A). It is clear that even strategies broadly representative
of the proteome like MudPIT may be saturated at the level
of MS detection. This is especially the case for the region
800–1100 Da, where nearly all unit peptide masses are
represented at least 30 times. This means that a mass ana-
lyzer with unit resolution or less (e.g. many quadrupole
and ion trap instruments) cannot resolve these peptides
from each other, but even an analyzer capable of resolving
to 0.1 Da in the range 800–1100 m/z would face many
peptides of similar mass. Certain protein or peptide
Proteome Science 2003, 1 http://www.Proteomesci.com/content/1/1/5
Page 9 of 15
(page number not for citation purposes)
enrichment protocols may simplify the peptide distribu-
tions sufficiently that proteins can be unambiguously
determined from one or more daughter peptides. We
anticipate that proteogest may be useful in this regard. For
instance, relatively rare amino acids (e.g. cysteine, tryp-
tophan) may be used in affinity capture experiments to
'normalize' the proteome because most proteins contain
small numbers of these amino acids. However, the pro-
portion of proteins containing no cysteines varies consid-
erably for different proteomes. The human proteome
contains just over 4% of proteins lacking cysteine while
the corresponding number for M. jannaschii is 15% (Fig.
3). These proteins would be excluded from proteome
analysis when using such reagents. We examined the dis-
tribution of cysteine- and tryptophan-containing peptides
in the trypsin-digested human proteome in more detail
(Fig. 5B). While 57.8% of peptides contain at least two
cysteines, 93.4% contain at least one (Fig. 5B). The corre-
sponding figures for tryptophan are 35.2% and 89.2%
(Fig. 5B). Having more than one peptide per protein
means that even if one affinity-trapped peptide remains
undetected by the mass spectrometer, a second opportu-
nity for detection may present itself. These figures are use-
ful because they represent a theoretical upper limit to the
number of peptides that may be detected by mass spec-
trometry using these approaches.
The experimentally determined proteome may contain
proteins that are naturally modified or that are modified
as part of the proteomics experiment. Examples of the
former class include acetylation, phosphorylation, and
glycosylation while examples of the latter include car-
boxymethylation and modification by quantitation rea-
gents such as ICAT or MCAT. It is intuitive that the
complexity of a mixture of digested proteins will be
greatly increased by differential modification, for instance
phosphorylation (Fig. 6A). It is currently impossible to
accurately predict the effects of chemical modification on
the behaviour of the corresponding ions in a mass spec-
trometer. Of interest to the proteomics researcher how-
ever, is to understand how the increased diversity affects
the distribution of predictable physical/chemical proper-
ties of the digest products. Even with current state-of-the-
art 2D chromatography-MS systems, the number of pep-
tides that need to be separated in a proteomics experiment
vastly exceeds the resolving ability of the separating chro-
matography columns and the time available for the mass
spectrometer to obtain a spectrum [17,18]. Calculations
using proteogest show how these modifications alter the
mass profiles of the modified peptides (Fig. 6B). Two gen-
eral comments may be made. First, where modification
reactions continue to completion, the mass distribution is
not significantly altered. The greatest change in mass dis-
tribution is in the lower mass ranges, and the change will
be proportional to the ratio of the donor group mass to
the accepting peptide mass. Addition of a phosphate
group to a serine on a peptide of mass 300 increases it's
mass by 27%. The region 800–1200 Da that is critical for
proteomics MS applications appears to be minimally
affected for the treatments simulated by proteogest (Fig.
6B). Note that other effects such as changes in peptide
ionization efficiency cannot be simulated may have a
major impact on the success of a proteomics experiment.
Moreover, when incomplete modification is simulated,
the more likely situation under laboratory conditions, the
total number of peptides to be analyzed greatly increases
(Fig. 6B).
Many proteins show homology across their whole length
or across portions of their sequence, therefore many of the
digestion products of such proteins may be identical. The
proteogest Redundancy function tabulates redundant
peptides at the bottom of the Summary report, listing
their sequence along with the cognate protein. Analysis of
the E. coli, S. pombe, S. cerevisiae proteomes show distinct
differences in the distribution of redundant tryptic pep-
tides (Fig. 7). On average, for every 184 E. coli tryptic pep-
tides (of at least seven amino acids) there is an identical
Table 1: Characteristics of peptide products following digestion of the yeast proteome with different agents.
Endo AspN CNBr Chymotrypsin Trypsin* (no 
missed cleavages)
Trypsin (zero or 
one missed 
cleavages)
Trypsin (zero, one 
or two missed 
cleavages)
Trypsin and 
chymo-trypsin
Total number of peptides in 
proteome
150,427 59,702 216,969 291,203 593,88 930,613 411,401
Mean peptide mass (isotopic) 2192.5 5554.2 1496.7 1229.2 1637.4 2078.5 614.1
Mean number of peptides 
per protein
24.2 9.6 35.0 41.9 95.7 150.0 66.3
*Idealized digestion criteria were used (in the laboratory, the rules governing cleavage may be more complex – for instance trypsin rarely cuts after 
arginine or lysine when the distal residue is proline). Here, the criteria used were: EndoAspN (X-D), CNBr (X-M), Chymotrypsin (X-L, X-F, X-Y, 
X-W), trypsin (K-X, R-X).
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Size distribution of peptides following digestion of the yeast and human proteomes with trypsinFigure 5
Size distribution of peptides following digestion of the yeast and human proteomes with trypsin. A) The distribution of peptides 
produced by the theoretical proteome (grey) is compared to that produced in experiment (black). Peptide masses are plotted 
at unit resolution (Da). The relatively lower numbers of peptides observed between 1600–2000 Da is an artefact resulting 
from MS runs being programmed to detect only ions with m/z in the range 400–1600. Identification of peptides with mass 
greater than 1600 is possible with ions of charge greater than one. B) Distribution of valine-, cysteine-, and tryptophan-contain-
ing peptides in the human proteome.
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Increased S. cerevisiae proteome complexity resulting from protein modification and incomplete protein cleavageFigure 6
Increased S. cerevisiae proteome complexity resulting from protein modification and incomplete protein cleavage. A) Number 
of tryptic peptides generated when serine, S, threonine, T, tyrosine, Y, or all three residues are phosphorylated. B) Effect of 
phosphorylation of serine, threonine, and tyrosine on distribution of tryptic peptide mass.
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Peptide redundancy in the E. coli, S. pombe, and S. cerevisiae proteomes following in silico digestion with trypsinFigur 7
Peptide redundancy in the E. coli, S. pombe, and S. cerevisiae proteomes following in silico digestion with trypsin. Only peptides 
of seven or more residues are considered.
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peptide elsewhere in the digested proteome. Meanwhile,
for every 49 S. cerevisiae or every 66 S. pombe tryptic pep-
tides, one has an identical counterpart in the proteome.
The figure for both yeast species is slightly skewed by the
presence of many transposon-derived elements in the
genome that are predicted to encode identical proteins. In
most cases, common peptides are from protein isoforms,
for instance enzyme dimers or the subunits of transport
complexes. 898 S. cerevisiae (14.5%), 540 S. pombe
(10.7%), and 176 E. coli (4.0%) proteins contain tryptic
peptides (> 7 aa) found elsewhere in the proteome,
reflecting relative numbers of homologous proteins in
these organisms, and perhaps in turn reflecting genome
duplication events [19]. From the perspective of the pro-
teomics researcher, it is not possible for peptide sequenc-
ing MS approaches to correctly resolve isoforms (or to
resolve homologs unless a peptide from one homolog
that is not found in a second homolog is observed).
Finally, protein identifications in proteomics experiments
usually rely on measurement of ionized peptides in a
mass spectrometer. Different peptides are known to have
different ionization properties in particular instruments,
yet the chemical or physical basis of this phenomenon is
poorly understood [20]. We used proteogest to compare
the frequency of different amino acid residues in the pre-
dicted tryptic products of the human and mouse pro-
teomes and in greater than 6,000 peptides detected by
electrospray mass spectrometry analysis of mouse liver
and lung tissue and validated using the SEQUEST and
STATQUEST algorithms [21] (Fig. 8). For most residues
the differences are minor. Assuming that SEQUEST has no
residue bias in matching tandem MS spectra to their cog-
nate peptides, arginine-, serine-, lysine-, and glutamic
acid-containing peptides are underrepresented in the
identified set, while glycine and particularly histidine are
overrepresented. Arginine- and lysine-containing peptides
are underrepresented because in silico cleavage forces all
such peptides to contain two of either residue (C- and N-
terminal), while mass spectrometry experiments often
detect peptides that contain only one such flanking resi-
due. Three times as many histidine-containing peptides
were identified than would be expected given their fre-
quency in the theoretical proteome. We speculate the his-
tidine-containing peptides are more readily detected
during electrospray mass spectrometry because the basic
histidine residue promotes ionization (as do lysine and
arginine). The rules governing ionization are based on a
combination of known and unknown physical and chem-
ical factors and are likely to be subtle, probably requiring
examination of the positions as well as frequency of a par-
ticular residue in the peptide, or the frequency of different
combinations of residues. We believe that proteogest may
prove to be useful in addressing this important issue.
Discussion
Currently, two main MS approaches are used to identify
proteins in proteomics experiments: a) 2D-PAGE separa-
tion combined with matrix assisted laser desorption ioni-
zation MS [22] and b) gel or chromatographic separation
combined with electrospray MS [23]. The former
approach uses the observed masses of intact peptide ions
derived from the same parent protein for identification
("peptide fingerprinting"), while the latter generally relies
on uninterpreted product mass spectra derived from a sin-
gle peptide ion. In both cases, database searching is nor-
mally used to match experimentally observed mass
spectra with spectra predicted for known protein
sequences. The efficiency of both approaches is depend-
ant on many factors, for example the accuracy, sensitivity
and resolution of the measuring instrument, and also the
size and distribution of peptide and protein properties in
proteome. proteogest permits descriptive statistics to be
obtained for whole proteome datasets and for in silico
digestion products of the proteomes. Normally, calculat-
ing these numbers requires a custom program to be writ-
ten for each query. Although such programs are relatively
simple, they require time and skills not always available in
a busy proteomics lab. We therefore wrote proteogest to
answer questions about the physical/chemical properties
of theoretical proteomes, in order to design practical
experiments.
The software tool is timely and valuable for several rea-
sons. First, it permits the testing of hypotheses concerning
the entire proteome (or large subsets thereof). For
instance, one might ask whether yeast nuclear proteins are
enriched in particular (e.g. acidic) amino acids by com-
paring the fraction of certain residues (e.g. aspartic acid
and glutamic acid) found in nuclear localized proteins as
compared with the overall proteome. To do this, proteogest
is first run on a FASTA file of the complete yeast proteome
and then on a similar file edited to include only proteins
annotated to the nucleus. Second, the distribution of pro-
teins or peptides can be incorporated into probability-
based mass spectrum identification algorithms. For
instance, the mean number of tryptic peptides per protein
for E. coli is 28, but 42 for C. elegans, so the fragmentation
patterns expected for a typical protein will the different in
the different organisms. Furthermore, automated de novo
peptide sequencing (identification of a peptide sequence
solely from the spectrum itself, and not by comparison
with a spectrum predicted using a DNA database) is cur-
rently achievable only using specialized high-resolution
mass spectrometers (e.g. Fourier Transform MS) or by
chemical modification of the peptides before MS analysis,
such as using MCAT [13]. Knowing the relative occurrence
of different amino acids (or pairs of successive amino
acids) for a given proteome for instance, can facilitate the
probability of de novo sequencing predictions. Third, pro-
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Comparison of amino acid residue frequency in tryptic peptides from lung tissue proteome identified by electrospray mass 
spectrometry ('Identified tryptic proteome') and in the in silico trypsin digested combined human and mouse proteomes ('The-
oretical tryptic proteome'). Residue frequencies are expressed as a fraction of the analyzed proteome (e.g. serine, S, comprises 
8.5% of the theoretical tryptic proteome versus 6.8% of the identified tryptic proteome). Note that the occurrence of arginine 
(R) and lysine (K) are artificially reduced in the Identified tryptic proteome because non fully-tryptic peptides (i.e. peptides with 
residues other than R or K at their C-termini) form a significant fraction of peptides identified by SEQUEST.
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teogest can be used for the planning and interpretation of
experimental proteomics applications, in particular those
involving high throughput protein identifications using
MS. For instance, the ICAT method for protein relative
abundance determination [16] relies on the modification
of cysteine-containing peptides. When designing a pro-
teomics experiment using ICAT, it is important to calcu-
late the proportion of all proteins that contain one or
more cysteines, yet currently, there is no easy way to carry
out this apparently trivial calculation without writing a
program. Finally, we show how proteogest can be used to
search for patterns in proteomics data, for instance the fre-
quency of particular amino acid residues in observed ver-
sus predicted peptides.
Materials and Methods
Datasets
Files containing the protein sequence of all proteins pre-
dicted using the genomic DNA sequences of Escherchia
coli, Methanococcus jannaschii, Saccharomyces cerevisiae,
Schizosaccharomyces pombe, Caenorhabditis elegans, Dro-
sophilia melanogaster, and Homo sapiens were downloaded
from the European Bioinformatics website http://
www.ebi.org on 20 August 2002. The experimental S. cer-
evisiae proteome determined by 2D-MALDI was obtained
by combining datasets observed by Futcher and coworkers
[15] and Gygi and coworkers [14]. The proteome dataset
determined by 1D LCMS was obtained from our labora-
tory using methods described in Cagney and Emili [13].
The 2D MUDPIT proteome dataset comprised proteins
observed by Washburn and coworkers [6] and in our lab-
oratory. The experimentally determined sets are subsets of
the complete predicted S. cerevisiae proteome FASTA file
and proteogest is used in exactly the same way except that
the input files are edited to include only relevant proteins.
Peptides detected by mass spectrometry following trypsin
digestion of whole cell extract of S. cerevisiae were
obtained in our laboratory using MUDPIT [16,21] and
identified using the SEQUEST algorithm [5] searched
against all predicted fully tryptic peptides in the non-
redundant SwissProt and TrEMBL mouse and human pro-
tein sequences downloaded from EBI in December 2002.
SEQUEST scores demonstrated to yield approximately
98% correct identifications were included in the analysis
[21].
proteogest
The software is open source and can be requested by
email. The program is written in Perl and works on major
operating systems (Windows, Unix, Linux). A helpfile can
be downloaded from the Emili website and gives instruc-
tions on installing and using the program.
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